All products are for Professional Use Only (PUO) — not intended for human or animal consumption

Back to Learn
Growth Hormone & PerformancePeptide

IGF-1 LR3

A long-acting analog of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. Studies have investigated its enhanced anabolic activity and reduced IGF binding protein affinity.

Mechanism of Action

IGF-1 LR3 (Long Arg3 IGF-1) is an 83-amino acid analog of human IGF-1 engineered with two key modifications: substitution of glutamic acid with arginine at position 3 (Arg3), and extension of the N-terminus by 13 amino acids. These changes dramatically reduce binding affinity for IGF binding proteins (IGFBPs 1-6), which normally sequester and inactivate circulating IGF-1. As a result, IGF-1 LR3 has a significantly longer half-life and greater bioavailability than native IGF-1. It activates the IGF-1 receptor (IGF-1R) to stimulate protein synthesis, glucose uptake, and cell proliferation through the PI3K/Akt and MAPK/ERK signaling pathways.

Research Applications

  • Studies have investigated enhanced anabolic signaling due to reduced IGFBP sequestration
  • Research has examined muscle hypertrophy and recovery signaling in cell culture and animal models
  • Studies have explored its effects on glucose metabolism and insulin sensitivity pathways
  • Biotechnology applications in cell culture media and bioprocess optimization

Key Published Studies

1

Francis GL, et al. Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. Biochem J. 1988;251(1):95-103.

Key finding: Characterized the enhanced biological potency of IGF-1 analogs with reduced IGFBP binding, establishing the pharmacological rationale for the LR3 modification.

2

Tomas FM, et al. Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection. J Endocrinol. 1996;150(1):77-84.

Key finding: Demonstrated that IGF-1 LR3 maintained its superior potency over native IGF-1 in modulating nitrogen retention and anabolic signaling pathways when administered by injection in research models.

Chemical Properties

TypePeptide (IGF-1 analog, 83 amino acids)

Research Use Only (RUO): This page summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. The compound described carries a Research Use Only designation and is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in the diagnosis, treatment, cure, or prevention of any disease. Consult qualified professionals before making any health-related decisions.

i2b Health Research Supply
RESEARCH USE ONLY

Age Verification Required

You must be 21 years of age or older to access this website. All products are intended for qualified researchers and laboratory use only.

By entering this site, you confirm that you are at least 21 years of age, that anything you acquire here is for research purposes, and that you agree to our Terms of Service and Research Use Only policy. Products are not intended for human or animal consumption.